K. Shannon

K. Shannon, L. Haydu, J. Thompson, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies.

K. Shannon, R. Scolyer, G. Long, 2021, European journal of cancer.

Proposed Quality Standards for Regional Lymph Node Dissections in Patients With Melanoma

K. Shannon, R. Scolyer, R. Saw, 2009, Annals of surgery.

BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting

Stephen B. Fox, S. Prakash, K. Shannon, 2021, Pathology.

γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival

R. Tothill, K. Shannon, J. Wilmott, 2021, Cancer Immunology Research.

Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1–2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center

K. Shannon, R. Scolyer, L. Haydu, 2016, Annals of Surgical Oncology.

Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01).

R. Fisher, K. Shannon, R. Scolyer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Traumatic vertebro‐jugular arteriovenous fistula successfully treated by percutaneous embolization

K. Shannon, G. White, G. Parker, 2001, ANZ journal of surgery.

Lessons learnt from an apparent lack of clinical response following superficial radiation therapy of cutaneous squamous cell carcinoma

K. Shannon, G. Fogarty, A. Ziebell, 2019 .

Comprehensive Characterization of Cancer Driver Genes and Mutations

Steven J. M. Jones, Christopher A. Miller, Joshua M. Stuart, 2018, Cell.

Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites

K. Shannon, J. Wilmott, R. Scolyer, 2022, Journal for ImmunoTherapy of Cancer.

Survival outcomes of perineural spread in head and neck cutaneous squamous cell carcinoma

Jonathan R. Clark, K. Shannon, S. Ch’ng, 2022, ANZ journal of surgery.

1220PDPhase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

K. Shannon, R. Scolyer, R. Kefford, 2017 .

Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma

K. Shannon, R. Scolyer, L. Haydu, 2012, Annals of surgery.

Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.

R. Fisher, K. Shannon, R. Scolyer, 2015, The Lancet. Oncology.

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

K. Shannon, R. Scolyer, K. Sikorska, 2022, Nature Medicine.

Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome

N. Ajami, K. Shannon, J. Wargo, 2022, Nature Medicine.

Dramatic reduction of chronic lymphoedema of the lower limb with sorafenib therapy.

K. Shannon, P. Hersey, M. Moncrieff, 2008, Melanoma research.

Outcome of treatment for advanced cervical metastatic squamous cell carcinoma

C. O'brien, K. Shannon, K. Gao, 2005, Head & neck.

Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation

C. O'brien, K. Shannon, S. Clarke, 2004, ANZ journal of surgery.

Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life

R. Fisher, K. Shannon, R. Scolyer, 2019, Annals of Surgical Oncology.

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.

R. Fisher, K. Shannon, R. Scolyer, 2012, The Lancet. Oncology.

Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes.

P. V. van Diest, K. Shannon, R. Scolyer, 2022, European journal of cancer.

Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.

P. V. van Diest, K. Shannon, R. Scolyer, 2022, European journal of cancer.

The Optimum Excision Margin and Regional Node Management for Primary Cutaneous T3 Melanomas (2–4 mm in Thickness): A Retrospective Study of 1587 Patients Treated at a Single Center

K. Shannon, R. Scolyer, L. Haydu, 2014, Annals of surgery.

Effect of the SunSafe Student Ambassador Program on the attitudes, knowledge and behaviour of Australian high‐school students towards sun safety: a prospective study

Derek S. Bryan, K. Shannon, R. Scolyer, 2022, Clinical and experimental dermatology.

Bone resection for facial cutaneous malignancies

Jonathan R. Clark, K. Shannon, S. Ch’ng, 2017, Journal of Surgical Oncology.

Free flap reconstruction for melanoma of the head and neck: indications and outcomes.

Jonathan R. Clark, C. O'brien, K. Shannon, 2010, Journal of Plastic, Reconstructive & Aesthetic Surgery.

False-negative sentinel node biopsy because of obstruction of lymphatics by metastatic melanoma: the value of ultrasound in conjunction with preoperative lymphoscintigraphy

K. Shannon, R. Scolyer, M. Quinn, 2009, Melanoma research.

Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidism

Jonathan R. Clark, C. O'brien, K. Shannon, 2009, ANZ journal of surgery.

Papillary Endothelial Hyperplasia of the Orbit

K. Shannon, R. Karim, G. Watson, 2007, Acta Cytologica.

Prospective study of sentinel node biopsy for high‐risk cutaneous squamous cell carcinoma of the head and neck

Jonathan R. Clark, K. Shannon, W. Kelder, 2016, Head & neck.

Soft Tissue Metastases in Head and Neck Cutaneous Squamous Cell Carcinoma

Jonathan R. Clark, K. Shannon, S. Ch’ng, 2020, The Laryngoscope.

Orbital exenterations: an 18‐year experience from a single head and neck unit

Jonathan R. Clark, K. Shannon, K. Gao, 2011, ANZ journal of surgery.

Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes

J. Shah, C. O'brien, K. Shannon, 2006, Cancer.

The Unpredictability of Lymphatic Drainage from the Ear in Melanoma Patients, and Its Implications for Management

K. Shannon, L. Haydu, J. Stretch, 2013, Annals of Surgical Oncology.

The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma

Jonathan R. Clark, K. Shannon, S. Ch’ng, 2021, Head & neck.

Sentinel Node Biopsy in 105 High-Risk Cutaneous SCCs of the Head and Neck: Results of a Multicenter Prospective Study

Jonathan R. Clark, K. Shannon, S. Ch’ng, 2019, Annals of Surgical Oncology.

Management of the neck in patients with T1 and T2 cancer in the mouth.

C. O'brien, K. Shannon, K. Gao, 2004, The British journal of oral & maxillofacial surgery.

Determinants of outcome in melanoma patients with cerebral metastases.

K. Shannon, J. Thompson, G. Stevens, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience with 998 cutaneous melanomas of the head and neck over 30 years.

C. O'brien, K. Shannon, A. Coates, 1991, American journal of surgery.

Surgical management of the neck in patients with metastatic melanoma in parotid lymph nodes

K. Shannon, R. Scolyer, S. Ch’ng, 2019, Journal of surgical oncology.

Assessment of second tier lymph nodes in melanoma and implications for extent of elective neck dissection in metastatic cutaneous malignancy of the parotid

Jonathan R. Clark, K. Shannon, S. Ch’ng, 2013, Head & neck.

Superselective neck dissection after chemoradiation: feasibility based on clinical and pathologic comparisons.

K. Shannon, K. Robbins, F. Vieira, 2007, Archives of otolaryngology--head & neck surgery.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

Perineural invasion in oral squamous cell carcinoma: Quantitative subcategorisation of perineural invasion and prognostication

Jonathan R. Clark, K. Shannon, K. Gao, 2015, Journal of surgical oncology.

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets

J. Pearson, K. Shannon, G. Mann, 2019, Nature Communications.

Histological regression in melanoma: impact on sentinel lymph node status and survival

K. Shannon, R. Scolyer, M. El Sharouni, 2021, Modern Pathology.

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

J. Pearson, K. Shannon, G. Mann, 2021, Cancer cell.

Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma

Carsten E Palme, Bing Yu, N Gopalakrishna Iyer, 2018, Modern Pathology.

Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma

Jonathan R. Clark, K. Shannon, K. Gao, 2011, Head & neck.

Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma.

K. Shannon, J. Wilmott, R. Scolyer, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcome Following Sentinel Node Biopsy Plus Wide Local Excision Versus Wide Local Excision Only for Primary Cutaneous Melanoma: Analysis of 5840 Patients Treated at a Single Institution

K. Shannon, R. Scolyer, L. Haydu, 2014, Annals of surgery.

In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy

K. Shannon, R. Scolyer, L. Haydu, 2015, Annals of Surgical Oncology.

Clinical outcomes following surgical treatment of lentigo maligna of the head and neck.

K. Shannon, R. Scolyer, P. Guitera, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case–Control Study

K. Shannon, R. Scolyer, L. Haydu, 2016, Annals of Surgical Oncology.

The Importance of Adequate Primary Tumor Excision Margins and Sentinel Node Biopsy in Achieving Optimal Locoregional Control for Patients With Thick Primary Melanomas

K. Shannon, R. Scolyer, L. Haydu, 2013, Annals of surgery.

Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy

C. O'brien, K. Shannon, R. Scolyer, 2004, Annals of Surgical Oncology.

Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center

K. Shannon, G. Mann, R. Scolyer, 2017, Modern Pathology.

Cutaneous Melanoma of the Head and Neck

C. O'brien, K. Shannon, 2009 .

Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma

K. Shannon, R. Scolyer, G. Long, 2021, Annals of Surgical Oncology.

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

V. Sondak, M. Ross, K. Shannon, 2022, Annals of Surgical Oncology.

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.

K. Shannon, J. Wilmott, R. Scolyer, 2019, The Lancet. Oncology.

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

K. Shannon, A. Broeks, T. Schumacher, 2019, The Lancet. Oncology.

Correlation Between Preoperative Lymphoscintigraphy and Metastatic Nodal Disease Sites in 362 Patients With Cutaneous Melanomas of the Head and Neck

C. O'brien, K. Shannon, R. Scolyer, 2004, Annals of surgery.

Is high-risk cutaneous squamous cell carcinoma of the head and neck a suitable candidate for current targeted therapies?

Jonathan R. Clark, K. Shannon, N. Iyer, 2019, Journal of Clinical Pathology.

Reticular and microcystic schwannoma of the parotid gland.

J. Kench, K. Shannon, Charles Chan, 2013, Pathology.

Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility

J. Pearson, K. Shannon, G. Mann, 2018, International journal of cancer.

Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets.

K. Shannon, J. Wilmott, R. Scolyer, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Immunotherapy‐induced sarcoidosis in patients with melanoma treated with PD‐1 checkpoint inhibitors: Case series and immunophenotypic analysis

K. Shannon, S. V. van Hal, P. Hersey, 2017, International Journal of Rheumatic Diseases.

Topical diphencyprone immunotherapy for cutaneous metastatic melanoma

K. Shannon, R. Saw, D. Damian, 2009, The Australasian journal of dermatology.

Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.

Jeffrey E. Lee, M. Ross, K. Shannon, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications

K. Shannon, R. Saw, A. Spillane, 2017, Annals of Surgical Oncology.

Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

K. Shannon, A. Broeks, T. Schumacher, 2021, Nature Medicine.

Frequency and duration of remission after isolated limb perfusion for melanoma.

P. Kam, K. Shannon, J. Thompson, 1997, Archives of surgery.

How important is multidisciplinary treatment of melanoma metastases

K. Shannon, G. Fogarty, A. Guminski, 2013 .

Isolated limb infusion for melanoma: Results of an elective double infusion protocol

P. Kam, K. Shannon, R. Saw, 1995 .

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.

K. Shannon, G. Mann, R. Scolyer, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease

K. Shannon, R. Scolyer, L. Haydu, 2014, Annals of Surgical Oncology.

Small Cell Neuroendocrine Carcinoma Masquerading as Cellulitis and Causing Blindness via Bilateral Orbital Involvement

K. Shannon, Alp Atik, M. Krilis, 2013, Orbit.

Primary Melanoma Location on the Scalp is an Important Risk Factor for Brain Metastasis: A Study of 1,687 Patients with Cutaneous Head and Neck Melanomas

K. Shannon, L. Haydu, R. Saw, 2014, Annals of Surgical Oncology.

Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma

K. Shannon, K. Drzewiecki, S. Lo, 2022, Annals of Surgical Oncology.

Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients?

Jonathan R. Clark, C. O'brien, K. Shannon, 2008, Annals of surgical oncology.

Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01).

R. Fisher, K. Shannon, R. Scolyer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiplex melanoma families are enriched for polygenic risk

M. Iles, D. Duffy, N. Martin, 2020, Human Molecular Genetics.

Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system

K. Shannon, R. Scolyer, Kevin B. Kim, 2020, Cancer.

Higher polygenic risk for melanoma is associated with improved survival

D. Bishop, M. Iles, K. Shannon, 2022, medRxiv.

Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage iiib/c BRAF-V600 mutation positive melanoma.

K. Shannon, R. Scolyer, R. Kefford, 2016 .

Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread

K. Shannon, R. Scolyer, G. Long, 2022, Melanoma research.

Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma.

Jonathan R. Clark, K. Shannon, M. Cowley, 2019, The Journal of investigative dermatology.

Primary dermal melanoma: clinical behaviour, prognosis and treatment.

K. Shannon, R. Scolyer, R. Karim, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Abstract 5734: Gut microbiota predicts response and toxicity with neoadjuvant immunotherapy

K. Shannon, J. Wilmott, R. Scolyer, 2020, Tumor Biology.

Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach

K. Shannon, J. Wilmott, R. Scolyer, 2023, Journal of Translational Medicine.

Oral Cavity Reconstruction over a 30-Year Period at a Dedicated Tertiary Head and Neck Cancer Centre

K. Shannon, S. Ch’ng, C. Palme, 2022, Indian Journal of Surgery.

Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma Metastasis.

K. Shannon, R. Scolyer, L. Haydu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.

K. Shannon, R. Scolyer, J. Thompson, 2019 .

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas

K. Shannon, G. Mann, N. Hayward, 2019, Oncotarget.